SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (1025)7/23/1997 11:36:00 PM
From: Jim   of 6136
 
Is there a built in expectation for Agouron to be profitable this upcoming (August) report? One thing to remember is that this stock has a fair amount of momentum investors in it. I hope that they arent expecting AGPH to have a profit this quarter. They may be disappointed.

One of the things that seems to have been overlooked in one of the earlier posts, is that revenues and net income are different. You can make a calculation of revs per share, but not all of it will be in AGPHs net income per share. There is a cost per share to get those earnings. This is their margins. Any ideas on what they will have for margins?? We may not know until after the Aug report.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext